Ginkgo Bioworks Holdings Inc - Company Profile
Powered by
All the data and insights you need on Ginkgo Bioworks Holdings Inc in one report.
- Save hours of research time and resources with
our up-to-date Ginkgo Bioworks Holdings Inc Strategy Report
- Understand Ginkgo Bioworks Holdings Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Ginkgo Bioworks Holdings Inc (Ginkgo Bioworks) is a biotechnology company that builds a leading platform for cell programming and biosecurity and provides automated organism engineering, enzyme discovery, fermentation and cultured fragrance solutions through its subsidiary. The company is into genetic engineering to produce bacteria with industrial applications. Its cell programming platform is used to program cells to enable the biological production of products, such as food ingredients, novel therapeutics and chemicals. Ginkgo Bioworks offerings include vaccines, enzymes, proteins, small molecules, strain optimization, fermentation and scale-up and biosecurity. The company serves industries including agriculture, specialty chemicals, food, consumer products and pharmaceuticals. Ginkgo Bioworks is headquartered in Boston, Massachusetts, the US.
Ginkgo Bioworks Holdings Inc premium industry data and analytics
Products and Services
Services |
---|
Cell Programming Services |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Contracts/Agreements | In May, the company partnered with GreenLab to scale the production of brazzein. |
2024 | Contracts/Agreements | In May, the company partnered with Sojitz Corp to build connections with Japanese businesses and develop sustainable production processes. |
2024 | Asset Purchase | In April, the company acquired Modulus Therapeutics' cell therapy platform assets. |
Competitor Comparison
Key Parameters | Ginkgo Bioworks Holdings Inc | Cromsource Inc | H&J CRO International Inc | Kindred Healthcare LLC | Medpace Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Boston | Cary | Union | Louisville | Cincinnati |
State/Province | Massachusetts | North Carolina | New Jersey | Kentucky | Ohio |
No. of Employees | 1,292 | - | - | 33,000 | 5,600 |
Entity Type | Public | Private | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Marijn E. Dekkers | Chairman | Executive Board | - | 66 |
Jason Kelly | Director; Chief Executive Officer | Executive Board | 2008 | 43 |
Reshma Shetty | Director; President; Chief Operating Officer | Executive Board | 2008 | 43 |
Mark Dmytruk | Chief Financial Officer | Senior Management | 2020 | 52 |
Steven P. Coen | Chief Accounting Officer | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer